CytoTools AG
Symbol: T5O.DE
XETRA
0.408
EURMarkedspris i dag
-4.3146
P/E-forhold
2.0710
PEG Ratio
1.84M
MRK Cap
- 0.00%
DIV Udbytte
CytoTools AG (T5O-DE) Årsregnskaber
Balance
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 5.84 | 1.8 | 0 | 1.6 | ||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | -0.2 | ||||||||||||||
balance-sheet.row.net-receivables | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.inventory | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.other-current-assets | 0.27 | 0.1 | 0.1 | 0.1 | ||||||||||||||
balance-sheet.row.total-current-assets | 6.24 | 2 | 0.1 | 1.7 | ||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.intangible-assets | 0 | 0 | 0 | 0.1 | ||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 0 | 0 | 0.1 | ||||||||||||||
balance-sheet.row.long-term-investments | 79.62 | 19.7 | 18.2 | 20.5 | ||||||||||||||
balance-sheet.row.tax-assets | -20.16 | 0 | 0 | 20.6 | ||||||||||||||
balance-sheet.row.other-non-current-assets | 0.53 | -19.7 | -18.2 | -20.6 | ||||||||||||||
balance-sheet.row.total-non-current-assets | 79.66 | 19.7 | 18.2 | 20.6 | ||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.total-assets | 85.89 | 21.6 | 18.3 | 22.3 | ||||||||||||||
balance-sheet.row.account-payables | 0.16 | 0 | 0.1 | 0.1 | ||||||||||||||
balance-sheet.row.short-term-debt | 0 | 0 | 0.1 | 0 | ||||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 0 | 0.1 | 0 | ||||||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0.08 | - | - | - | ||||||||||||||
balance-sheet.row.other-current-liab | 0.28 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0.33 | 0.1 | 0.2 | 0.3 | ||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.total-liab | 0.77 | 0.2 | 0.4 | 0.4 | ||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.common-stock | 20.55 | 5.1 | 4 | 4 | ||||||||||||||
balance-sheet.row.retained-earnings | -86.42 | -21.4 | -20.6 | -16.6 | ||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 76.34 | 0.4 | 0.4 | 34.5 | ||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 74.59 | 37.3 | 34 | 0 | ||||||||||||||
balance-sheet.row.total-stockholders-equity | 85.05 | 21.4 | 17.9 | 21.9 | ||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 85.82 | 21.6 | 18.3 | 22.3 | ||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.total-equity | 85.05 | 21.4 | 17.9 | 21.9 | ||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 85.82 | - | - | - | ||||||||||||||
Total Investments | 79.62 | 19.7 | 18.2 | 20.3 | ||||||||||||||
balance-sheet.row.total-debt | 0 | 0 | 0.1 | 0 | ||||||||||||||
balance-sheet.row.net-debt | -5.84 | -1.8 | 0.1 | -1.6 |
Pengestrømsopgørelse
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -0.66 | -0.8 | -4.1 | -1.8 | ||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 0 | 2.5 | 0 | ||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.change-in-working-capital | 0.01 | -0.1 | -0.1 | 0.2 | ||||||||||||||
cash-flows.row.account-receivables | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.inventory | 0.01 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.account-payables | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.other-working-capital | 0 | -0.1 | -0.1 | 0.2 | ||||||||||||||
cash-flows.row.other-non-cash-items | 0.07 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -0.58 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | 0 | -0.1 | 0 | ||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -1.5 | 0 | -4.8 | ||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.other-investing-activites | -1.97 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -1.97 | -1.5 | -0.1 | -4.8 | ||||||||||||||
cash-flows.row.debt-repayment | 0 | -0.1 | 0 | 0 | ||||||||||||||
cash-flows.row.common-stock-issued | 0 | 4.4 | 0 | 0 | ||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.other-financing-activites | -0.16 | 0 | 0 | 6 | ||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -0.16 | 4.2 | 0 | 6 | ||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.net-change-in-cash | -2.72 | 1.8 | -1.7 | -0.4 | ||||||||||||||
cash-flows.row.cash-at-end-of-period | -2.72 | 1.8 | -0.1 | 1.6 | ||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 0 | 1.6 | 2 | ||||||||||||||
cash-flows.row.operating-cash-flow | -0.58 | -0.9 | -1.6 | -1.7 | ||||||||||||||
cash-flows.row.capital-expenditure | 0 | 0 | -0.1 | 0 | ||||||||||||||
cash-flows.row.free-cash-flow | -0.58 | -0.9 | -1.7 | -1.7 |
Resultatopgørelse række
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0.02 | 0 | 0 | 0 | ||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 0 | 0.5 | 0.7 | ||||||||||||||
income-statement-row.row.gross-profit | 0.02 | 0 | -0.5 | -0.7 | ||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||
income-statement-row.row.other-expenses | 0 | 0 | 0 | 0 | ||||||||||||||
income-statement-row.row.operating-expenses | 0.71 | 0.8 | 1.6 | 1.1 | ||||||||||||||
income-statement-row.row.cost-and-expenses | 0.71 | 0.8 | 1.6 | 1.9 | ||||||||||||||
income-statement-row.row.interest-income | 0.02 | 0 | 0 | 0 | ||||||||||||||
income-statement-row.row.interest-expense | 0 | 0 | 0 | 0 | ||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0.02 | 0 | -2.5 | 0 | ||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 0 | 0 | ||||||||||||||
income-statement-row.row.total-operating-expenses | 0.02 | 0 | -2.5 | 0 | ||||||||||||||
income-statement-row.row.interest-expense | 0 | 0 | 0 | 0 | ||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 0 | 2.5 | 0 | ||||||||||||||
income-statement-row.row.ebitda-caps | -0.68 | - | - | - | ||||||||||||||
income-statement-row.row.operating-income | -0.69 | -0.8 | -1.6 | -1.8 | ||||||||||||||
income-statement-row.row.income-before-tax | -0.66 | -0.8 | -4 | -1.8 | ||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 0 | 0 | 0 | ||||||||||||||
income-statement-row.row.net-income | -0.66 | -0.8 | -4.1 | -1.8 |
Ofte stillede spørgsmål
Hvad er CytoTools AG (T5O.DE) samlede aktiver?
CytoTools AG (T5O.DE) samlede aktiver er 21607950.000.
Hvad er virksomhedens årlige omsætning?
Den årlige omsætning er 12412.000.
Hvad er virksomhedens profitmargin?
Virksomhedens profitmargin er 1.000.
Hvad er virksomhedens frie pengestrøm?
Det frie cash flow er -0.082.
Hvad er virksomhedens nettoprofitmargin?
Nettofortjenstmargenen er -29.508.
Hvad er firmaets samlede omsætning?
Den samlede omsætning er -30.361.
Hvad er CytoTools AG (T5O.DE) nettoresultat (nettoindkomst)?
Nettoresultatet (nettoindkomsten) er -829837.250.
Hvad er virksomhedens samlede gæld?
Den samlede gæld er 0.000.
Hvad er tallet for driftsudgifter?
Driftsudgifterne er 835230.000.
Hvad er firmaets likviditet?
Virksomhedens likviditet er 1081631.000.